$PCRX
Pacira BioSciences, Inc. Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000110465913038693 Filed on May 08, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$11.59M	$7.804M
YoY Change	48.48%	102.02%
Cost Of Revenue	$11.39M	$6.495M
YoY Change	75.38%	77.12%
Gross Profit	$196.0K	$1.309M
YoY Change	-85.03%	567.86%
Gross Profit Margin	1.69%	16.77%
Selling, General & Admin	$12.94M	$11.15M
YoY Change	16.0%	216.55%
% of Gross Profit	6600.0%	851.95%
Research & Development	$5.905M	$1.294M
YoY Change	356.34%	-65.9%
% of Gross Profit	3012.76%	98.85%
Depreciation & Amortization	$1.431M	$1.380M
YoY Change	3.7%	39.39%
% of Gross Profit	730.1%	105.42%
Operating Expenses	$30.23M	$18.94M
YoY Change	59.61%	72.43%
Operating Profit	-$18.65M	-$11.14M
YoY Change	67.41%	56.37%
Interest Expense	$1.519M	$514.0K
YoY Change	195.53%	-79.28%
% of Operating Profit
Other Income/Expense, Net	-$4.935M	-$757.0K
YoY Change	551.92%	-71.47%
Pretax Income	-$23.58M	-$11.90M
YoY Change	98.15%	21.43%
Income Tax	-$442.0K	$0.00
% Of Pretax Income
Net Earnings	-$23.14M	-$11.89M
YoY Change	94.54%	21.68%
Net Earnings / Revenue	-199.69%	-152.41%
Basic Earnings Per Share	-$0.71	-$0.47
Diluted Earnings Per Share	-$0.71	-$0.47
COMMON SHARES
Basic Shares Outstanding	32.71M shares	25.37M shares
Diluted Shares Outstanding	32.71M shares	25.37M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.2M	$54.80M
YoY Change	101.09%	-7.59%
Cash & Equivalents	$26.27M	$25.21M
Short-Term Investments	$84.00M	$29.60M
Other Short-Term Assets	$2.700M	$1.500M
YoY Change	80.0%	36.36%
Inventory	$10.76M	$5.078M
Prepaid Expenses
Receivables	$5.243M	$860.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$129.0M	$62.26M
YoY Change	107.16%	-2.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.13M	$26.49M
YoY Change	55.25%	8.57%
Goodwill	$8.582M
YoY Change
Intangibles		$4.746M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.845M	$762.0K
YoY Change	404.59%	-30.73%
Total Long-Term Assets	$56.25M	$32.00M
YoY Change	75.79%	-5.6%
TOTAL ASSETS
Total Short-Term Assets	$129.0M	$62.26M
Total Long-Term Assets	$56.25M	$32.00M
Total Assets	$185.2M	$94.26M
YoY Change	96.51%	-3.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.001M	$2.302M
YoY Change	-56.52%	-62.26%
Accrued Expenses	$9.872M	$7.040M
YoY Change	40.23%	85.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$900.0K	$1.364M
YoY Change	-34.02%	-81.06%
Total Short-Term Liabilities	$12.70M	$19.16M
YoY Change	-33.72%	-2.75%
LONG-TERM LIABILITIES
Long-Term Debt	$95.86M	$23.63M
YoY Change	305.62%	5.5%
Other Long-Term Liabilities	$2.694M	$2.675M
YoY Change	0.71%	-89.13%
Total Long-Term Liabilities	$98.55M	$26.31M
YoY Change	274.62%	-44.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.70M	$19.16M
Total Long-Term Liabilities	$98.55M	$26.31M
Total Liabilities	$115.4M	$57.02M
YoY Change	102.46%	-14.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$255.7M	-$192.1M
YoY Change	33.06%
Common Stock	$33.00K	$25.00K
YoY Change	32.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000K	$2.000K
YoY Change	0.0%
Treasury Stock Shares	1.065K shares	1.065K shares
Shareholders Equity	$69.79M	$37.24M
YoY Change
Total Liabilities & Shareholders Equity	$185.2M	$94.26M
YoY Change	96.51%	-3.71%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$23.14M	-$11.89M
YoY Change	94.54%	21.68%
Depreciation, Depletion And Amortization	$1.431M	$1.380M
YoY Change	3.7%	39.39%
Cash From Operating Activities	-$13.79M	-$17.55M
YoY Change	-21.42%	339.85%
INVESTING ACTIVITIES
Capital Expenditures	$2.932M	$2.901M
YoY Change	1.07%	-449.52%
Acquisitions
YoY Change
Other Investing Activities	-$53.32M	$370.0K
YoY Change	-14510.81%
Cash From Investing Activities	-$56.25M	-$2.530M
YoY Change	2123.32%	204.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	86.19M	-880.0K
YoY Change	-9894.32%	-102.31%
NET CHANGE
Cash From Operating Activities	-13.79M	-17.55M
Cash From Investing Activities	-56.25M	-2.530M
Cash From Financing Activities	86.19M	-880.0K
Net Change In Cash	16.15M	-20.96M
YoY Change	-177.05%	-163.13%
FREE CASH FLOW
Cash From Operating Activities	-$13.79M	-$17.55M
Capital Expenditures	$2.932M	$2.901M
Free Cash Flow	-$16.72M	-$20.45M
YoY Change	-18.23%	547.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2013Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33047004	shares
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10126000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1523000	USD
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	30924000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4352000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	12077000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1920000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	60922000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39116000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	8297000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3208000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511000	USD
CY2012Q4	us-gaap	Assets Assets	112054000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2569000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9792000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	823000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14156000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25191000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	857000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3720000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2275000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	46199000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-232520000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	65855000	USD
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	298317000	USD
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2013Q1	us-gaap	Revenues Revenues	11587000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12698000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	69792000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112054000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	115449000	USD
CY2013Q1	us-gaap	Assets Assets	185241000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	128989000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32960170	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32959105	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32624049	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32622984	shares
CY2013Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	446000	USD
CY2012Q1	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	6490000	USD
CY2012Q1	us-gaap	Royalty Revenue RoyaltyRevenue	868000	USD
CY2012Q1	us-gaap	Revenues Revenues	7804000	USD
CY2012Q1	us-gaap	Cost Of Revenue CostOfRevenue	6495000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1294000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11152000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	18941000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11137000	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	63000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	514000	USD
CY2012Q1	us-gaap	Royalty Expense RoyaltyExpense	282000	USD
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-24000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-757000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-11894000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	25367306	shares
CY2013Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3398000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-23138000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4935000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18645000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	30232000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11892000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23121000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	17000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1380000	USD
CY2012Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-56000	USD
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	103000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	712000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1299000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1253000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3833000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-366000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-613000	USD
CY2012Q1	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	93000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6166000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-17545000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2901000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	371000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2530000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	153000	USD
CY2012Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	685000	USD
CY2012Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	348000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-880000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	16146000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-20955000	USD
CY2012Q1	us-gaap	Interest Paid InterestPaid	1168000	USD
CY2013Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	120000000	USD
CY2013Q1	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	284000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-56251000	USD
CY2013Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	71785000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13789000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25213000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46168000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26272000	USD
CY2013Q1	us-gaap	Short Term Investments ShortTermInvestments	83974000	USD
CY2013Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	83930000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	66000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	22000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30897000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	28000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1000	USD
CY2013Q1	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	item
CY2012	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	item
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2737000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4081000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4237000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5979000	USD
CY2013Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3786000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2017000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	10760000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50719000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	52614000	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11484000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11603000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41130000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	900000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	900000	USD
CY2013Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2012Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2013Q1	pcrx	Goodwill Recorded For Earn Out Payments GoodwillRecordedForEarnOutPayments	600000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2695000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1537000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	755000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	322000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	81000	USD
CY2013Q1	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	120000000	USD
CY2012Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	27500000	USD
CY2013Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	24143000	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2309000	USD
CY2013Q1	us-gaap	Long Term Debt LongTermDebt	95857000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	25191000	USD
CY2013Q1	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	853000	USD
CY2013Q1	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	723000	USD
CY2013Q1	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1576000	USD
CY2013Q1	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	97433000	USD
CY2012Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	26871000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2225000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	712000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5204537	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4823679	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	380858	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32709000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25367000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32709000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25367000	shares
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2225000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	17000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9872000	USD
CY2012Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1680000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5243000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2740000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	8582000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3845000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1001000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	95857000	USD
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3477000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2694000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325375000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5905000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-255658000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	44000	USD
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185241000	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10835000	USD
CY2013Q1	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	243000	USD
CY2013Q1	us-gaap	Royalty Revenue RoyaltyRevenue	509000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	11391000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12936000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	73000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	1519000	USD
CY2013Q1	us-gaap	Royalty Expense RoyaltyExpense	86000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32709298	shares
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	17000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	877000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1431000	USD
CY2013Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	94000	USD
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	855000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2225000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1523000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	891000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1317000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	868000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	162000	USD
CY2013Q1	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	104000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	450000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-243000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2932000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	18750000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	877000	USD
CY2013Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	27500000	USD
CY2013Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7191000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	86186000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	23956000	USD
CY2013Q1	pcrx	Equity Premium Convertible Debt EquityPremiumConvertibleDebt	24936000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3325000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4589000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4782000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4927000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4858000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	13131000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	35612000	USD

Files In Submission

Name	View Source	Status
0001104659-13-038693-index-headers.html	Edgar Link	pending
0001104659-13-038693-index.html	Edgar Link	pending
0001104659-13-038693.txt	Edgar Link	pending
0001104659-13-038693-xbrl.zip	Edgar Link	pending
a13-8037_110q.htm	Edgar Link	pending
a13-8037_1ex31d1.htm	Edgar Link	pending
a13-8037_1ex31d2.htm	Edgar Link	pending
a13-8037_1ex32d1.htm	Edgar Link	pending
a13-8037_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
pcrx-20130331.xml	Edgar Link	completed
pcrx-20130331.xsd	Edgar Link	pending
pcrx-20130331_cal.xml	Edgar Link	unprocessable
pcrx-20130331_def.xml	Edgar Link	unprocessable
pcrx-20130331_lab.xml	Edgar Link	unprocessable
pcrx-20130331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira BioSciences, Inc. Stock $pcrx

2013 Q1 Form 10-Q Financial Statement

#000110465913038693 Filed on May 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira BioSciences, Inc. Stock $pcrx

2013 Q1 Form 10-Q Financial Statement

#000110465913038693 Filed on May 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira BioSciences, Inc. Stock $pcrx